Results 21 to 30 of about 2,867,692 (324)

Brief Story on Prostaglandins, Inhibitors of their Synthesis, Hematopoiesis, and Acute Radiation Syndrome

open access: yesMolecules, 2019
Prostaglandins and inhibitors of their synthesis (cyclooxygenase (COX) inhibitors, non-steroidal anti-inflammatory drugs) were shown to play a significant role in the regulation of hematopoiesis. Partly due to their hematopoiesis-modulating effects, both
Michal Hofer   +2 more
doaj   +1 more source

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management

open access: yesJournal of Neuroinflammation, 2019
Epilepsy, a common multifactorial neurological disease, affects about 69 million people worldwide constituting nearly 1% of the world population.
C. Rawat   +3 more
semanticscholar   +1 more source

NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase

open access: yesInternational Journal of Molecular Sciences, 2022
Acute inflammation or resolved inflammation is an adaptive host defense mechanism and is self-limiting, which returns the body to a state of homeostasis.
Oluwafunke R. Kolawole, K. Kashfi
semanticscholar   +1 more source

Antimetastatic activity of a cyclooxygenase-2 inhibitor [PDF]

open access: yesBritish Journal of Cancer, 2004
Cyclooxygenase-2 (COX-2) expression is increased in breast cancer and surgery has been shown to increase the growth of metastatic tumours. We investigated the effect of selective COX-2 inhibition on the growth of metastases in either an experimental metastasis model or following excision of a murine primary breast tumour.
Judith H. Harmey   +4 more
openaire   +3 more sources

Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis

open access: yesDrugs & Aging, 2019
ObjectiveOur aim was to assess the safety of cyclooxygenase-2 (COX-2) inhibitors in the management of osteoarthritis (OA) in a systematic review and meta-analysis of randomized, placebo-controlled trials.MethodsA comprehensive literature search was ...
E. Curtis   +13 more
semanticscholar   +1 more source

Effect of multiple-dose regimens of cyclooxygenase inhibitors and their combinations with mexidol on behavior in mature rats

open access: yesФармакокинетика и Фармакодинамика, 2023
Effects of multiple-dose regimens (oral, daily, once a day for 15 days) of cyclooxygenase (COX) inhibitors etoricoxib (1 and 10 mg/kg), diclofenac sodium (1 and 5 mg/kg) and their combinations with 2-ethyl-6-methyl-3-hydroxypyridine succinate (mexidol 25
E. A. Ivanova   +3 more
doaj   +1 more source

SELECTIVE CYCLOOXYGENASE-2 INHIBITORS

open access: yesRheumatic Disease Clinics of North America, 1999
The identification of COX-2 less than a decade ago has been followed by an unprecedented period of discovery and drug development. An awareness of the existence of two COX isoforms has led to potential novel insights into disease pathogenesis (arthritis, Alzheimer's disease, cancer) and the regulation of normal physiology (brain, kidney).
Brian D. Golden, Steven B. Abramson
openaire   +2 more sources

Nonsteroidal anti-inflammatory drugs and acetaminophen ameliorate muscular mechanical hyperalgesia developed after lengthening contractions via cyclooxygenase-2 independent mechanisms in rats.

open access: yesPLoS ONE, 2019
Nonsteroidal anti-inflammatory drugs and acetaminophen are cyclooxygenase inhibitors commonly used as symptomatic medicines for myofascial pain syndrome.
Tetsuhiro Shimodaira   +2 more
doaj   +1 more source

Antiproliferative Benzoindazolequinones as Potential Cyclooxygenase-2 Inhibitors

open access: yesMolecules, 2019
Quinones and nitrogen heterocyclic moieties have been recognized as important pharmacophores in the development of antitumor agents. This study aimed to establish whether there was any correlation between the in silico predicted parameters and the in ...
Aurora Molinari   +7 more
doaj   +1 more source

Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants [PDF]

open access: yesKorean Journal of Pediatrics, 2017
PurposePlasma level of B-type natriuretic peptide (BNP), an emerging, sensitive, and specific biomarker of hemodynamically significant patent ductus arteriosus (PDA), rapidly decreases in infants receiving cyclooxygenase inhibitors for ductal closure. We
Jeonghee Shin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy